These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 16543916

  • 1. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
    Miyahara R, Banerjee S, Kawano K, Efferson C, Tsuda N, Miyahara Y, Ioannides CG, Chada S, Ramesh R.
    Cancer Gene Ther; 2006 Aug; 13(8):753-61. PubMed ID: 16543916
    [Abstract] [Full Text] [Related]

  • 2. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
    Gopalan B, Litvak A, Sharma S, Mhashilkar AM, Chada S, Ramesh R.
    Cancer Res; 2005 Apr 15; 65(8):3017-24. PubMed ID: 15833826
    [Abstract] [Full Text] [Related]

  • 3. Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation-associated -7 (mda-7)/interleukin-24 (IL-24) gene.
    Saito Y, Miyahara R, Gopalan B, Litvak A, Inoue S, Shanker M, Branch CD, Mhashilkar AM, Roth JA, Chada S, Ramesh R.
    Cancer Gene Ther; 2005 Mar 15; 12(3):238-47. PubMed ID: 15578066
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic and specific antitumor immunity induced by co-administration of immature dendritic cells and adenoviral vector expressing biologically active IL-18.
    Tanaka F, Hashimoto W, Robbins PD, Lotze MT, Tahara H.
    Gene Ther; 2002 Nov 15; 9(21):1480-6. PubMed ID: 12378411
    [Abstract] [Full Text] [Related]

  • 5. MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 family.
    Chada S, Sutton RB, Ekmekcioglu S, Ellerhorst J, Mumm JB, Leitner WW, Yang HY, Sahin AA, Hunt KK, Fuson KL, Poìndexter N, Roth JA, Ramesh R, Grimm EA, Mhashilkar AM.
    Int Immunopharmacol; 2004 May 15; 4(5):649-67. PubMed ID: 15120650
    [Abstract] [Full Text] [Related]

  • 6. Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients.
    Tong AW, Nemunaitis J, Su D, Zhang Y, Cunningham C, Senzer N, Netto G, Rich D, Mhashilkar A, Parker K, Coffee K, Ramesh R, Ekmekcioglu S, Grimm EA, van Wart Hood J, Merritt J, Chada S.
    Mol Ther; 2005 Jan 15; 11(1):160-72. PubMed ID: 15585417
    [Abstract] [Full Text] [Related]

  • 7. The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer.
    Zhao L, Dong A, Gu J, Liu Z, Zhang Y, Zhang W, Wang Y, He L, Qian C, Qian Q, Liu X.
    Cancer Gene Ther; 2006 Nov 15; 13(11):1011-22. PubMed ID: 16799468
    [Abstract] [Full Text] [Related]

  • 8. mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review).
    Lebedeva IV, Emdad L, Su ZZ, Gupta P, Sauane M, Sarkar D, Staudt MR, Liu SJ, Taher MM, Xiao R, Barral P, Lee SG, Wang D, Vozhilla N, Park ES, Chatman L, Boukerche H, Ramesh R, Inoue S, Chada S, Li R, De Pass AL, Mahasreshti PJ, Dmitriev IP, Curiel DT, Yacoub A, Grant S, Dent P, Senzer N, Nemunaitis JJ, Fisher PB.
    Int J Oncol; 2007 Nov 15; 31(5):985-1007. PubMed ID: 17912425
    [Abstract] [Full Text] [Related]

  • 9. [Effects of adenoviral-mediated melanoma differentiation associated gene-7/IL-24 on growth and apoptosis of breast cancer cells].
    Ni QC, Yang L, Zhang CH, Zhou F, Zhu HJ, Huang JF.
    Zhonghua Yi Xue Za Zhi; 2008 Nov 18; 88(42):3008-11. PubMed ID: 19080082
    [Abstract] [Full Text] [Related]

  • 10. Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism.
    Chada S, Mhashilkar AM, Ramesh R, Mumm JB, Sutton RB, Bocangel D, Zheng M, Grimm EA, Ekmekcioglu S.
    Mol Ther; 2004 Dec 18; 10(6):1085-95. PubMed ID: 15564140
    [Abstract] [Full Text] [Related]

  • 11. mda-7/IL-24 inhibits the proliferation of hematopoietic malignancies in vitro and in vivo.
    Dong CY, Zhang F, Duan YJ, Yang BX, Lin YM, Ma XT.
    Exp Hematol; 2008 Aug 18; 36(8):938-46. PubMed ID: 18468766
    [Abstract] [Full Text] [Related]

  • 12. Mice vaccination with interleukin 12-transduced colon cancer cells potentiates rejection of syngeneic non-organ-related tumor cells.
    Adris S, Chuluyan E, Bravo A, Berenstein M, Klein S, Jasnis M, Carbone C, Chernajovsky Y, Podhajcer OL.
    Cancer Res; 2000 Dec 01; 60(23):6696-703. PubMed ID: 11118055
    [Abstract] [Full Text] [Related]

  • 13. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
    Hwang KS, Cho WK, Yoo J, Seong YR, Kim BK, Kim S, Im DS.
    Cancer Gene Ther; 2004 Jun 01; 11(6):397-407. PubMed ID: 15044962
    [Abstract] [Full Text] [Related]

  • 14. Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer.
    Yu DS, Lee CF, Hsieh DS, Chang SY.
    Urology; 2004 Mar 01; 63(3):596-601. PubMed ID: 15028475
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo.
    Saeki T, Mhashilkar A, Swanson X, Zou-Yang XH, Sieger K, Kawabe S, Branch CD, Zumstein L, Meyn RE, Roth JA, Chada S, Ramesh R.
    Oncogene; 2002 Jul 04; 21(29):4558-66. PubMed ID: 12085234
    [Abstract] [Full Text] [Related]

  • 16. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
    Slos P, De Meyer M, Leroy P, Rousseau C, Acres B.
    Cancer Gene Ther; 2001 May 04; 8(5):321-32. PubMed ID: 11477452
    [Abstract] [Full Text] [Related]

  • 17. Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodes.
    Søndergaard H, Galsgaard ED, Bartholomaeussen M, Straten PT, Odum N, Skak K.
    J Immunother; 2010 Apr 04; 33(3):236-49. PubMed ID: 20445344
    [Abstract] [Full Text] [Related]

  • 18. In vivo antitumor activity of interleukin 21 mediated by natural killer cells.
    Wang G, Tschoi M, Spolski R, Lou Y, Ozaki K, Feng C, Kim G, Leonard WJ, Hwu P.
    Cancer Res; 2003 Dec 15; 63(24):9016-22. PubMed ID: 14695220
    [Abstract] [Full Text] [Related]

  • 19. Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis.
    Lebedeva IV, Su ZZ, Sarkar D, Gopalkrishnan RV, Waxman S, Yacoub A, Dent P, Fisher PB.
    Oncogene; 2005 Jan 20; 24(4):585-96. PubMed ID: 15580305
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.
    Oniki S, Nagai H, Horikawa T, Furukawa J, Belladonna ML, Yoshimoto T, Hara I, Nishigori C.
    Cancer Res; 2006 Jun 15; 66(12):6395-404. PubMed ID: 16778218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.